Study of Single Oral Doses of HOPO 14-1 Evaluating Safety, Tolerability, Pharmacokinetics
Clinical trial NCT05628961 · COMPLETED
Trial details
- NCT number
- NCT05628961
- Sponsor
- SRI International
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2025-08-04
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.